Medical devices, healthcare technology and the business of care
510(k) clearance · K261655

RT Elements (4.6)

Brainlab SE · Decision date Oct 5, 2026

MEDTECHLEDGER EXPLANATIONK261655

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for RT Elements (4.6), a Brainlab SE radiation therapy treatment planning software submission, on October 5, 2026, under 21 CFR 892.5050 with product codes MUJ and QIH. The public database lists the application as received May 19, 2026, while the FDA letter and 510(k) summary are dated September 10, 2026; the record does not reconcile that difference. SESE is a 510(k) clearance, not premarket approval.

The stated indication covers stereotactic, conformal, computer-planned, linac-based radiation treatment planning for cranial, head and neck and extracranial lesions, in adults only. The summary names RT Elements (4.5), K250440, as predicate and lists modules including Multiple Brain Mets SRS, Cranial SRS, Spine SRS, Cranial SRS w/ Cones, RT Contouring, RT QA, Dose Review and Brain Mets Retreatment Review. The record does not identify which specific changes distinguish 4.6 from 4.5, and no clinical performance data are summarized here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 5, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261655
Regulatory pathway
510(k) premarket notification
Applicant
Brainlab SE
Product code
MUJ
Decision code
SESE
Decision date
Oct 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Planning, Radiation Therapy Treatment.

Applicant
Brainlab SE
Product code
MUJ
FDA device class
2

FDA decision timeline

  1. K261655 received

    Application receipt date recorded by FDA.

  2. K261655 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Brainlab SE

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Munich

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records